Efficiency of homocysteine plus copper in inducing apoptosis is inversely proportional to γ‐glutamyl transpeptidase activity
- 24 July 2001
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 15 (11) , 1927-1940
- https://doi.org/10.1096/fj.00-0848com
Abstract
Hyperhomocysteinemia represents an independent risk factor for atherosclerosis, but the mechanisms leading to cellular dysfunctions remain unknown. Using ECV304 cells, we found that homocysteine (Hcy) plus copper (Cu2+) induced cytotoxic effects: loss of cell adhesion, increased permeability to PI, and the occurrence of morphologically apoptotic cells. This form of apoptosis, inhibited by Z-VAD-fmk, was associated with a loss of mitochondrial potential, a cytosolic release of cytochrome c, activation of caspase-3, degradation of poly(ADP-ribose)polymerase, and internucleosomal DNA fragmentation. However, the ability of Hcy plus Cu2+ to induce apoptosis decreased when the pretreatment culture time increased. As a positive correlation was found between the length of time of culture before treatment and the enhancement of gamma-glutamyl transpeptidase (gamma-GT) activity, we asked whether gamma-GT was involved in the control of Hcy plus Cu2+-induced apoptosis. Therefore, ECV304 cells were treated with either acivicin or dexamethasone, inhibiting and stimulating gamma-GT, respectively. In ECV304 cells and human umbilical venous endothelial cells, acivicin favored Hcy plus Cu2+-induced apoptosis whereas dexamethasone counteracted the apoptotic process. As acivicin and dexamethasone were also capable of modulating cell death in ECV304 cells treated with antitumoral drugs, our data emphasize that the involvement of gamma-GT in the control of apoptosis is not restricted to Hcy but also concerns other chemical compounds.Keywords
Funding Information
- Université de Bourgogne
- Conseil régional de Bourgogne-Franche-Comté
- Institut National de la Santé et de la Recherche Médicale
- Fondation pour la Recherche Médicale
- Fondation de France
This publication has 75 references indexed in Scilit:
- Novel Risk Factors for AtherosclerosisMayo Clinic Proceedings, 2000
- HOMOCYSTEINE METABOLISMAnnual Review of Nutrition, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1997
- Correlation between plasma homocyst(e)ine and aortic atherosclerosisAmerican Heart Journal, 1997
- Homocyst(e)ine: an important risk factor for atherosclerotic vascular diseaseCurrent Opinion in Lipidology, 1997
- Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identificationNature Genetics, 1994
- Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis.Circulation, 1990
- HomocystinemiaNew England Journal of Medicine, 1974
- Homocystinuria: An Enzymatic DefectScience, 1964